# Development of 3D Human Blood Brain Barrier Formation Assay

Canonical: https://abierto.us/opportunities/fda5212026

- Solicitation number: FDA_5212026
- Notice type: Special notice
- Status: Closed. Deadline was June 12, 2026 at 3:00 PM EDT
- Department: Department of Health and Human Services
- Agency: Food and Drug Administration
- Contracting office: FDA Office of Acq Grant SVCS (75F401)
- NAICS: 54171 Research and Development in the Physical, Engineering, and Life Sciences
- Product or service code: AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research
- Place of performance: Silver Spring, Maryland
- County: Montgomery County (FIPS 24031). https://abierto.us/counties/montgomery-county-md-24031
- City: Silver Spring. https://abierto.us/cities/silver-spring-md-2472450
- First posted: May 21, 2026
- Last posted: May 21, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/1764ed57f4194131a10d00f2c17150ef/view

## Description

The Food and Drug Administration (FDA) intends to award a Sole Source Firm Fixed Price Purchase order to MIMETAS B.V. 704 Quince Orchard RD, Suite 260 Gaithersburg, Maryland 20878-1752. In accordance with FAR Part 6.302-1 (a) (2)(ii) which states” Only one responsible source and no other supplies or services will satisfy agency requirement”. The purpose of this notice is to inform the public that the Food and Drug Administration (FDA) anticipates issuing a Firm Fixed Price Purchase Order.

**MINIMUM REQUIREMENTS:** See Attached Statement of Work This notice is not a request for competitive proposals. However, any party that believes it can meet this requirement as stated herein may submit a written capability statement that clearly supports and demonstrates their ability to perform the requirement. Capability statements must be received by the response date and time of this notice. Submissions will be reviewed to determine if they can meet the requirement.

A determination by the Government to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. It is anticipated that an award will be issued to MIMETAS B.V. within approximately ten (10) days after the date of this notice unless the Government determines that any other organization has the capability to meet this requirement.

**Response Date:** June 12, 2026, by 3.00PM EST. Please email responses to Hilda Aryeh –hilda.aryeh@fda.hhs.gov. Hilda Aryeh Contract Specialist

## Publications

- May 21, 2026: Special notice, due June 12, 2026 at 3:00 PM EDT. Notice 1764ed57f4194131a10d00f2c17150ef. https://sam.gov/workspace/contract/opp/1764ed57f4194131a10d00f2c17150ef/view

## Points of contact

- HILDA ARYEH, hilda.aryeh@fda.hhs.gov

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/fda5212026.